Medicare Enrolled

Dr. Vitor Pastorini Filho, M.D.

Medical Oncology · Fort Myers, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
14551 HOPE CENTER LOOP STE 200, Fort Myers, FL 33912
2392647026
Registered in NPPES since 2009
NPI: 1215165279 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pastorini Filho from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pastorini Filho? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pastorini Filho

Dr. Vitor Pastorini Filho is a medical oncology specialist in Fort Myers, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Pastorini Filho performed 113,490 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Pastorini Filho received a total of $16,554 from 81 pharmaceutical and/or device companies across 817 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pastorini Filho is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years of NPI registration ▲ Top 23% volume in FL $16,554 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 147010 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
113,490
Medicare services
Top 23% in FL for medical oncology
Not available
Unique patients (not deduplicated)
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Feraheme)
An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis.
54,060 $0 $4
Azacitidine chemotherapy injection
An injection of the medication azacitidine, measured at 1 mg per unit.
11,800 $0 $4
Iron sucrose injection (Venofer)
An injection of iron sucrose used to replenish iron levels in the body.
8,300 $0 $5
Anti-nausea injection (aprepitant) 7,410 $1 $5
Denosumab injection (Prolia/Xgeva) 7,080 $19 $51
Paclitaxel chemotherapy injection 4,165 $0 $2
Immune globulin infusion (Gammagard)
An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg.
3,062 $36 $108
Eflapegrastim injection, 0.1 mg
An injection of eflapegrastim-xnst administered at a dose of 0.1 mg.
2,508 $25 $116
Iron infusion (Monoferric) 2,500 $16 $57
Epoetin alfa injection (Procrit) for anemia
An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis.
2,330 $6 $23
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
1,772 $8 $9
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
1,722 $8 $29
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
1,250 $0 $3
Anti-nausea injection (Aloxi/palonosetron) 790 $1 $28
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
595 $94 $339
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
456 $10 $69
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
376 $12 $61
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
348 $62 $239
Anti-nausea injection (ondansetron/Zofran) 320 $0 $9
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
234 $97 $378
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
229 $46 $189
Intravenous drug injection
A procedure involving the administration of a medication or substance directly into a vein.
157 $27 $156
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
145 $1 $6
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
142 $1 $3
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
140 $82 $298
Carboplatin chemotherapy injection, 50 mg
Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection.
140 $2 $41
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
134 $7 $69
Normal saline infusion, 1000 cc
Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution.
105 $2 $7
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
94 $15 $56
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
88 $136 $556
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
79 $55 $206
Intravenous hydration infusion, 31-60 minutes
Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes.
78 $25 $156
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
76 $20 $79
Automated red blood cell count with calculations
A blood test that automatically counts red blood cells and performs additional calculations to assess blood health.
74 $5 $20
Intravenous infusion of new drug or substance, 1 hour or less
This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less.
71 $49 $178
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
62 $63 $197
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
61 $38 $109
Additional hour of intravenous hydration
This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy.
59 $10 $42
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
58 $131 $453
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
58 $17 $59
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
56 $21 $84
Methylprednisolone injection, up to 40 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg.
46 $3 $11
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
43 $2 $8
New patient office visit, complex (60-74 min) 38 $150 $585
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
36 $24 $89
Automated red blood cell count
An automated laboratory test that measures the number of red blood cells in a blood sample.
35 $4 $10
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
31 $140 $474
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
23 $100 $377
Normal saline infusion, 500 ml
Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution.
22 $1 $7
Venipuncture for blood collection
A procedure to draw blood from a vein for medical testing or analysis.
21 $61 $277
Bone marrow biopsy and aspiration
A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions.
11 $125 $467
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
53.3% high complexity
42.1% medium
4.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$16,554
Total received (2018-2024)
Avg $2,365/year across 7 years
Top 30% in FL for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
81
Companies
817
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,806
2023
$3,241
2022
$2,712
2021
$2,506
2020
$102
2019
$1,609
2018
$2,576

Payments by company (2024)

Novartis Pharmaceuticals Corporation
$409
Janssen Biotech, Inc.
$309
AstraZeneca Pharmaceuticals LP
$270
PFIZER INC.
$262
Merck Sharp & Dohme LLC
$255
Celgene Corporation
$226
Incyte Corporation
$184
JAZZ PHARMACEUTICALS INC.
$146
Takeda Pharmaceuticals U.S.A., Inc.
$134
ABBVIE INC.
$131
Gilead Sciences, Inc.
$121
Regeneron Healthcare Solutions, Inc.
$102
E.R. Squibb & Sons, L.L.C.
$101
Lilly USA, LLC
$98
Eisai Inc.
$93
GlaxoSmithKline, LLC.
$79
Genentech USA, Inc.
$77
Pharmacosmos Therapeutics Inc.
$72
ARRAY BIOPHARMA INC
$71
Bayer Healthcare Pharmaceuticals Inc.
$69
Alexion Pharmaceuticals, Inc.
$58
GENZYME CORPORATION
$58
Karyopharm Therapeutics Inc.
$57
PharmaEssentia USA Corporation
$48
Stemline Therapeutics Inc.
$44
Astellas Pharma US Inc
$44
Menarini Silicon Biosystems, Inc.
$38
Boehringer Ingelheim Pharmaceuticals, Inc.
$28
TerSera Therapeutics LLC
$26
Adaptive Biotechnologies Corporation
$21
TAIHO ONCOLOGY, INC.
$20
Agios Pharmaceuticals, Inc.
$20
Rigel Pharmaceuticals, Inc.
$20
BeiGene USA, Inc.
$19
PUMA BIOTECHNOLOGY, INC.
$18
Daiichi Sankyo Inc.
$17
Novocure Inc.
$16
SERVIER PHARMACEUTICALS LLC
$16
Mirati Therapeutics, Inc.
$16
Deciphera Pharmaceuticals Inc.
$15
Top 3 companies account for 26.0% of 2024 payments
All-time payments by company (2018-2024) ›
G1 Therapeutics, Inc.
$1,558
Novartis Pharmaceuticals Corporation
$1,214
Janssen Biotech, Inc.
$988
AstraZeneca Pharmaceuticals LP
$856
E.R. Squibb & Sons, L.L.C.
$796
GENZYME CORPORATION
$758
Celgene Corporation
$717
PFIZER INC.
$698
Genentech USA, Inc.
$633
Takeda Pharmaceuticals U.S.A., Inc.
$551
Merck Sharp & Dohme LLC
$550
Merck Sharp & Dohme Corporation
$504
Incyte Corporation
$491
Seagen Inc.
$438
Eisai Inc.
$389
Amgen Inc.
$352
Lilly USA, LLC
$345
Daiichi Sankyo Inc.
$322
Gilead Sciences, Inc.
$261
Regeneron Healthcare Solutions, Inc.
$237
JAZZ PHARMACEUTICALS INC.
$233
EISAI INC.
$196
Astellas Pharma US Inc
$185
ABBVIE INC.
$183
Alexion Pharmaceuticals, Inc.
$178
Pharmacyclics LLC, An AbbVie Company
$160
Octapharma USA, Inc.
$153
ARRAY BIOPHARMA INC
$144
GlaxoSmithKline, LLC.
$143
Bayer Healthcare Pharmaceuticals Inc.
$130
Rigel Pharmaceuticals, Inc.
$123
Karyopharm Therapeutics Inc.
$114
Clovis Oncology, Inc.
$105
Janssen Pharmaceuticals, Inc
$103
Kite Pharma, Inc.
$102
Boehringer Ingelheim Pharmaceuticals, Inc.
$95
MorphoSys, US Inc.
$83
Exelixis Inc.
$83
Ipsen Biopharmaceuticals, Inc
$82
Stemline Therapeutics Inc.
$78
Lexicon Pharmaceuticals, Inc.
$78
Pharmacosmos Therapeutics Inc.
$72
Bayer HealthCare Pharmaceuticals Inc.
$68
PharmaEssentia USA Corporation
$64
Mirati Therapeutics, Inc.
$53
SERVIER PHARMACEUTICALS LLC
$52
Deciphera Pharmaceuticals Inc.
$52
AVEO Pharmaceuticals, Inc.
$51
Adaptive Biotechnologies Corporation
$48
TESARO, Inc.
$44
BeiGene USA, Inc.
$38
TAIHO ONCOLOGY, INC.
$38
Menarini Silicon Biosystems, Inc.
$38
Genmab U.S., Inc.
$34
PUMA BIOTECHNOLOGY, INC.
$31
CTI BioPharma Corp.
$29
EMD Serono, Inc.
$28
Heron Therapeutics, Inc.
$27
TG THERAPEUTICS, INC.
$27
MEDIVATION FIELD SOLUTIONS LLC
$27
TerSera Therapeutics LLC
$26
Kyowa Kirin, Inc.
$21
Agios Pharmaceuticals, Inc.
$20
SOBI, INC
$19
CSL Behring
$19
Apellis Pharmaceuticals, Inc.
$18
Novocure Inc.
$16
Verastem, Inc.
$15
EUSA Pharma (US) LLC
$15
Array BioPharma Inc.
$15
Dova Pharmaceuticals
$15
Sobi, Inc
$14
Global Blood Therapeutics, Inc.
$14
Taiho Oncology, Inc.
$14
Foundation Medicine, Inc.
$13
Alnylam Pharmaceuticals Inc.
$13
Pharmacyclics LLC, an AbbVie Company
$13
Seattle Genetics, Inc.
$12
AbbVie Inc.
$12
Blueprint Medicines Corporation
$12
GE HEALTHCARE
$10
Top 3 companies account for 22.7% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Avastin · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · Braftovi · CALQUENCE · CERDELGA · CHANTIX · CINVANTI · COSELA · CREON · CYRAMZA · Cabometyx · Cellsearch · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · EXKIVITY · Empaveli · Enhertu · Epkinly · Erivedge · Erleada · FASLODEX · FOTIVDA · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · Gazyva · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · IRESSA · Idelvion · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · Optune · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Perjeta · Polivy · Pomalyst · QINLOCK · REBLOZYL · RETACRIT · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · Sylvant · TABRECTA · TAFINLAR · TAGRISSO · TASIGNA · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · Venclexta · Vonjo · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a medical oncology specialist in Fort Myers?
Compare medical oncologists in the Fort Myers area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists in nearby ZIP areas
15
County median income
$73,099
Nearest hospital to ZIP centroid (approximate)
GULF COAST MEDICAL CENTER LEE HEALTH
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pastorini Filho is a mixed practice specialist, with above-average Medicare volume (top 23% in FL), with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Pastorini Filho experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Pastorini Filho performed 54,060 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Pastorini Filho receive payments from pharmaceutical companies?
Yes. Dr. Pastorini Filho received a total of $16,554 from 81 companies across 817 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pastorini Filho's costs compare to other medical oncologists in Fort Myers?
Dr. Pastorini Filho's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pastorini Filho) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →